What are the common causes of thrombocytopenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Causes of Thrombocytopenia

Thrombocytopenia (platelet count <150,000/μL) results from four primary mechanisms: decreased bone marrow production, increased peripheral destruction, splenic sequestration, or dilution, with the most common causes being immune thrombocytopenia, drug-induced thrombocytopenia, bone marrow disorders, and infections. 1, 2

Major Mechanistic Categories

Decreased Platelet Production

  • Bone marrow disorders including myelodysplastic syndromes, leukemias, and other malignancies impair megakaryocyte function 1, 2
  • Aplastic anemia and megaloblastic anemia directly affect platelet production 2
  • Bone marrow fibrosis disrupts normal platelet generation 2
  • Viral infections can suppress bone marrow production of platelets 1
  • Inherited thrombocytopenias such as thrombocytopenia-absent radius syndrome, Wiskott-Aldrich syndrome, and MYH9-related disease affect platelet production 1, 2

Increased Platelet Destruction

Primary Immune Thrombocytopenia (ITP)

  • Primary ITP is an autoimmune disorder characterized by immunologic destruction of otherwise normal platelets, representing the most common cause in patients with isolated thrombocytopenia and no systemic illness 1, 2, 3

Secondary Immune Thrombocytopenia

  • Autoimmune disorders including systemic lupus erythematosus, antiphospholipid syndrome, and immune thyroid disease 1, 2
  • Infections including HIV, hepatitis C virus (HCV), and Helicobacter pylori 1, 2
  • Lymphoproliferative disorders such as chronic lymphocytic leukemia 1, 2
  • Common variable immune deficiency (CVID) can present with ITP as an initial feature 1
  • Recent vaccinations particularly measles, mumps, and rubella in children 1, 2

Drug-Induced Thrombocytopenia

  • Medication-related thrombocytopenia should always be considered and may be difficult to exclude 3
  • Drug-dependent antibody testing requires specialized immunoassays and should be collected during the acute thrombocytopenic episode or within 3 weeks, as antibodies disappear rapidly 1

Heparin-Induced Thrombocytopenia (HIT)

  • HIT is a serious antibody-mediated reaction that typically presents with moderate thrombocytopenia (30-70 × 10⁹/L) occurring 5-10 days after heparin initiation 1, 4
  • HIT can progress to heparin-induced thrombocytopenia with thrombosis (HITT), causing venous and arterial thromboses including deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction 4
  • The 4T score evaluates degree of thrombocytopenia, timing, presence of thrombosis, and absence of other causes 1

Thrombotic Microangiopathies

  • Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) cause increased platelet destruction 3
  • Disseminated intravascular coagulation (DIC) results in platelet consumption 1
  • Antiphospholipid syndrome can cause both thrombocytopenia and thrombosis 1

Pregnancy-Related Causes

  • Gestational thrombocytopenia is the most common cause in pregnancy, typically presenting with mild thrombocytopenia (platelet count >70,000/μL) 1
  • Preeclampsia and HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) can cause thrombocytopenia in pregnant patients 1

Splenic Sequestration

  • Liver disease with portal hypertension leads to splenomegaly and splenic sequestration of platelets 1
  • Hepatic disease with impaired hemostasis contributes to thrombocytopenia 2

Special Populations

  • Cyanotic congenital heart disease causes thrombocytopenia due to polycythemia and hyperviscosity triggering platelet consumption, with platelet counts inversely correlating with hematocrit levels 1
  • 22q11.2 deletion syndrome is associated with characteristically lower platelet counts and large platelets 1

Critical Diagnostic Distinctions

Red Flags Requiring Immediate Evaluation

When thrombocytopenia presents with any of the following, emergency hospitalization may be required 3, 5:

  • Splenomegaly, hepatomegaly, or lymphadenopathy suggests secondary causes rather than primary ITP 1, 3
  • Constitutional symptoms (fever, weight loss, bone pain) suggest underlying infection or malignancy 1, 3
  • Abnormal hemoglobin, white blood cell count, or white cell morphology indicates pancytopenia rather than isolated thrombocytopenia 1
  • Non-petechial rash is not typical of ITP 1
  • Schistocytes on peripheral smear suggest thrombotic microangiopathy 1

Pseudothrombocytopenia

  • EDTA-dependent platelet agglutination can falsely lower platelet counts and must be excluded by repeating the count in heparin or sodium citrate tubes 1, 3, 5

Clinical Severity and Bleeding Risk

  • Platelet count >50,000/μL: Generally asymptomatic 5
  • Platelet count 20,000-50,000/μL: Mild skin manifestations (petechiae, purpura, ecchymosis) 5
  • Platelet count <10,000/μL: High risk of serious bleeding 5

This algorithmic approach prioritizes life-threatening causes (HIT, TTP-HUS, HELLP syndrome) that require emergency intervention, followed by common causes (primary ITP, drug-induced) in stable patients, while systematically excluding pseudothrombocytopenia and secondary causes through targeted history, examination, and laboratory testing.

References

Guideline

Thrombocytopenia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Thrombocytopenia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Thrombocytopenia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Thrombocytopenia: Evaluation and Management.

American family physician, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.